A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice ( <scp>PIONEER REAL</scp> Japan): Subgroup analyses

Daisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, Rimei Nishimura, Yasuo Terauchi, Hanan Amadid, Uffe Christian Braae, Atheline Major‐Pedersen, Ryo Suzuki

Open source

DOI: 10.1111/jdi.70099
Published: 2025-07-25
Container: Journal of Diabetes Investigation
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jdi.70099,
  title = {A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (
                    <scp>PIONEER REAL</scp>
                    Japan): Subgroup analyses},
  author = {Daisuke Yabe and Yoshiyuki Hamamoto and Daiji Kawanami and Rimei Nishimura and Yasuo Terauchi and Hanan Amadid and Uffe Christian Braae and Atheline Major‐Pedersen and Ryo Suzuki},
  year = {2025},
  journal = {Journal of Diabetes Investigation},
  doi = {10.1111/jdi.70099},
  url = {https://doi.org/10.1111/jdi.70099}
}

RIS

TY  - JOUR
TI  - A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (
                    <scp>PIONEER REAL</scp>
                    Japan): Subgroup analyses
AU  - Daisuke Yabe
AU  - Yoshiyuki Hamamoto
AU  - Daiji Kawanami
AU  - Rimei Nishimura
AU  - Yasuo Terauchi
AU  - Hanan Amadid
AU  - Uffe Christian Braae
AU  - Atheline Major‐Pedersen
AU  - Ryo Suzuki
PY  - 2025
JO  - Journal of Diabetes Investigation
DO  - 10.1111/jdi.70099
UR  - https://doi.org/10.1111/jdi.70099
ER  -

APA

Yabe, D., Hamamoto, Y., Kawanami, D., Nishimura, R., Terauchi, Y., Amadid, H., Braae, U. C., Major‐Pedersen, A., & Suzuki, R. (2025). A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice ( <scp>PIONEER REAL</scp> Japan): Subgroup analyses. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70099

Source records

crossref · retrieved 2026-09-27T14:26:45.784Z